Skip to content

Quantification of Dilutional Anemia in the Initial Phase of Sepsis Management: Preliminary Retrospective Study

Quantification of Dilutional Anemia in the Initial Phase of Sepsis Management: Preliminary Retrospective Study: a Preliminary Retrospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06242561
Acronym
QUADS
Enrollment
208
Registered
2024-02-05
Start date
2023-06-01
Completion date
2023-09-01
Last updated
2024-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Keywords

hemoglobin levels

Brief summary

This is a single-center retrospective study conducted at Mercy hospital, aiming to investigate the correlation between changes in hemoglobin (Hb) levels and the volume of vascular refill administered during the first 48 hours.

Detailed description

Vascular refill is central to the initial management of hypotension in sepsis, and is often started even before the patient is admitted to intensive care. Over the past 20 years, we have moved from ultraliberal fluid resuscitation to restrictive resuscitation. Indeed, in the early 2000s, the implementation of an early and aggressive hemodynamic optimization strategy, including liberal vascular filling, improved the survival of critically ill patients, and ushered in the era of the Surviving Sepsis Campaign. However, studies have shown increased morbidity and mortality associated with a positive fluid balance. Restrictive approaches to fluid resuscitation and/or deressuscitation were then tested. While these approaches failed to demonstrate any benefit in terms of mortality, they did have the merit of demonstrating their feasibility and good tolerability, albeit with a little-explored pathophysiology. Little is known about the problem of dilutional anemia in the acute phase of septic shock.

Interventions

BEHAVIORALData collection from sepsis management

observational study

Sponsors

Centre Hospitalier Régional Metz-Thionville
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with septic shock, admitted to Mercy hospital between November 1, 2022 and July 31, 2023, with Noradrenaline administration for at least 6 hours and at least 2 hemoglobin measurements during the first 48 hours of resuscitation.

Exclusion criteria

* patients with acute bleeding or blood transfusion before or during the first 48 hours of resuscitation.

Design outcomes

Primary

MeasureTime frameDescription
Total volume of fluids administered during the first 48 hours of ICU stay48 hours from ICU admissionTotal volume of fluids (ml)

Secondary

MeasureTime frameDescription
Haemoglobinemia48 hours from ICU admissionHaemoglobinemia (g/dl)
Type of fluids administered during the first 48 hours of ICU stay48 hours from ICU admissionresuscitation, nutrition, maintenance // crystalloids, colloids, dextrose, sodium bicarbonate
Volume of fluids administered before admission in ICU (ml)at ICU admissionVolume of fluids (ml)
In hospital mortalityat hospital discharge : an average of 15 daysrate
Length of hospital stayat hospital discharge : an average of 15 daysLength of hospital stay (days)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026